FDA Clears Spineart's PERLA® App for Use with eCential Robotics' Op.n™ Navigation Platform
• The U.S. FDA has granted 510(k) clearance for Spineart's PERLA® TL application to be used with eCential Robotics' Op.n™ robotic navigation platform, marking a significant advancement in robotic-assisted spine surgery.
• The newly approved application integrates Spineart's PERLA® TL Open and MIS screw systems with eCential's platform, offering a navigation-specific interface and dedicated instruments designed to enhance surgical precision and workflow efficiency.
• The collaboration expands compatibility with various 3D C-arms, enabling hospitals to optimize existing resources through modular solutions while providing cutting-edge robotic navigation technology for spine surgeries.
© Copyright 2025. All Rights Reserved by MedPath